Health Care & Life Sciences » Biotechnology | Myriad Genetics Inc.

Myriad Genetics Inc.

Myriad Genetics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
70.92 M
Public Float
44.82 M
Myriad Genetics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.3
Market Cap
$2.03 B
Shares Outstanding
73.37 M
Public Float
71.43 M

Profile

Address
320 Wakara Way
Salt Lake City Utah 84108
United States
Employees -
Website http://www.myriad.com
Updated 07/08/2019
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing that is designed to asses a risk of developing a disease later in life of an individual.

Financials

View All

Mark C. Capone
President, Chief Executive Officer & Director
John Tannahill Henderson
Chairman